Anaphylactic Reaction

In early August, the FDA approved neffy epinephrine nasal spray to treat emergent type 1 allergic reactions in patients who weigh at least 66 pounds.

Dietary advancement therapy using a milk ladder shows that cow’s milk can be safely reintroduced to infants with a cow’s milk allergy, according to a study in Pediatric Allergy and Immunology.

The FDA has approved neffy epinephrine nasal spray for emergency treatment of Type 1 allergic reactions, including anaphylaxis, in pediatric and adult individuals weighing at least 66 pounds.

ARS Pharma recently announced that the FDA will likely rule on a new drug application for the company’s neffy epinephrine nasal spray — designed to treat type 1 allergic reactions such as anaphylaxis — by Oct. 2.